Cargando…
Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
[Image: see text] The antimicrobial lipopeptides polymyxin B and E (colistin) are being used as a ‘last-line’ therapy for infections caused by multidrug-resistant Gram-negative pathogens. Polymyxin resistance implies a total lack of antibiotics for the treatment of life-threatening infections caused...
Autores principales: | Velkov, Tony, Roberts, Kade D., Nation, Roger L., Wang, Jiping, Thompson, Philip E., Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033650/ https://www.ncbi.nlm.nih.gov/pubmed/24601489 http://dx.doi.org/10.1021/cb500080r |
Ejemplares similares
-
Probing the Penetration of Antimicrobial Polymyxin
Lipopeptides into Gram-Negative Bacteria
por: Deris, Zakuan Z., et al.
Publicado: (2014) -
A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
por: Deris, Zakuan Z., et al.
Publicado: (2013) -
Design and Evaluation of Novel Polymyxin Fluorescent Probes
por: Yun, Bo, et al.
Publicado: (2017) -
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens
por: Roberts, Kade D., et al.
Publicado: (2022) -
Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
por: Tran, Thien B., et al.
Publicado: (2018)